Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections

The paper shows a completely new immunotherapy for chronic hepatitis B and potentially also hepatitis D. The immunotherapy induced neutralizing antibodies and T

Saved in:
Bibliographic Details
Main Authors: Maravelia, Panagiota (Author) , Frelin, Lars (Author) , Ni, Yi (Author) , Caro Pérez, Noelia (Author) , Ahlén, Gustaf (Author) , Jagya, Neetu (Author) , Verch, Georg (Author) , Verhoye, Lieven (Author) , Pater, Lena (Author) , Johansson, Magnus (Author) , Pasetto, Anna (Author) , Meuleman, Philip (Author) , Urban, Stephan (Author) , Sällberg, Matti (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: The journal of infectious diseases
Year: 2020, Volume: 223, Issue: 1, Pages: 128-138
ISSN:1537-6613
DOI:10.1093/infdis/jiaa036
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/infdis/jiaa036
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/jid/article/223/1/128/5717223
Get full text
Author Notes:Panagiota Maravelia, Lars Frelin, Yi Ni, Noelia Caro Pérez, Gustaf Ahlén, Neetu Jagya, Georg Verch, Lieven Verhoye, Lena Pater, Magnus Johansson, Anna Pasetto, Philip Meuleman, Stephan Urban, and Matti Sällberg
Description
Summary:The paper shows a completely new immunotherapy for chronic hepatitis B and potentially also hepatitis D. The immunotherapy induced neutralizing antibodies and T
Item Description:Published online January 29, 2020
Gesehen am 26.02.2021
Physical Description:Online Resource
ISSN:1537-6613
DOI:10.1093/infdis/jiaa036